Analytical Data
-
Gene name
C1orf61
- Application
-
Alternative Names
C1orf61; CROC4Protein CROC-4; Contingent replication of cDNA 4
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13536
-
Expression Region
1-156aa
-
AA Sequence
MFLTEDLITFNLRNFLLFQLWESSFSPGAGGFCTTLPPSFLRVDDRATSSTTDSSRAPSSPRPPGSTSHCGISTRCTERCLCVLPLRTSQVPDVMAPQHDQEKFHDLAYSCLGKSFSMSNQDLYGYSTSSLALGLAWLSWETKKKNVLHLVGLDSL
-
Molecular Weight
43.56 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf61, also known as "chromosome 1 open reading frame 61," has gained interest in recent years due to its potential role in various biological processes and diseases. Initially identified in genomic studies, C1orf61 was thought to be a protein-coding gene with implications in cellular functions. Research has revealed its involvement in the regulation of cellular pathways, possibly influencing cell proliferation and apoptosis. The recombinant expression of C1orf61 protein is essential for further elucidating its functional roles, particularly in oncological and developmental contexts. Studies indicate that altered expression levels of C1orf61 may correlate with certain cancers, suggesting its potential as a biomarker or therapeutic target. Additionally, understanding the structure and function of the recombinant C1orf61 could provide insights into its interactions with other proteins and its contribution to disease mechanisms. Overall, the exploration of C1orf61 recombinant protein represents a promising avenue for advancing our knowledge of its biological significance and potential clinical applications.
